Literature DB >> 9655755

Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema.

F Xu1, J W Severinghaus.   

Abstract

The mechanism by which hypoxia causes high-altitude cerebral edema (HACE) is unknown. Tissue hypoxia triggers angiogenesis, initially by expressing vascular endothelial growth factor (VEGF), which has been shown to increase extracerebral capillary permeability. This study investigated brain VEGF expression in 32 rats exposed to progressively severe normobaric hypoxia (9-6% O2) for 0 (control), 3, 6, or 12 h or 1, 2, 3, or 6 days. O2 concentration was adjusted intermittently to the limit of tolerance by activity and intake, but no attempt was made to detect HACE. Northern blot analysis demonstrated that two molecular bands of transcribed VEGF mRNA (approximately 3.9 and 4.7 kb) were upregulated in cortex and cerebellum after as little as 3 h of hypoxia, with a threefold increase peaking at 12-24 h. Western blot revealed that VEGF protein was increased after 12 h of hypoxia, reaching a maximum in approximately 2 days. The expression of flt-1 mRNA was enhanced after 3 days of hypoxia. We conclude that VEGF production in hypoxia is consistent with the hypothesis that angiogenesis may be involved in HACE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655755     DOI: 10.1152/jappl.1998.85.1.53

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  10 in total

1.  The Hypoxia Hilton: recollections of a visit, with a postscript by J W Severinghaus on mechanisms of acute mountain sickness.

Authors:  J G Jones
Journal:  J R Soc Med       Date:  2002-12       Impact factor: 5.344

2.  Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia.

Authors:  S J Mandriota; C Pyke; C Di Sanza; P Quinodoz; B Pittet; M S Pepper
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  Physiological adjustments and arteriolar remodelling within skeletal muscle during acclimation to chronic hypoxia in the rat.

Authors:  K Smith; J M Marshall
Journal:  J Physiol       Date:  1999-11-15       Impact factor: 5.182

4.  Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest.

Authors:  Henry W Querfurth; Philip Lieberman; Steve Arms; Steve Mundell; Michael Bennett; Craig van Horne
Journal:  BMC Neurol       Date:  2010-11-01       Impact factor: 2.474

5.  Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.

Authors:  Michelle Sands; Katherine Howell; Christine M Costello; Paul McLoughlin
Journal:  Respir Res       Date:  2011-01-25

6.  Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy.

Authors:  Jacek Kowalczyk; Dorota Domal-Kwiatkowska; Urszula Mazurek; Michał Zembala; Bogdan Michalski; Marian Zembala
Journal:  Cell Mol Biol Lett       Date:  2007-02-12       Impact factor: 5.787

Review 7.  Metabolic Regulation of Hypoxia-Inducible Factors in Hypothalamus.

Authors:  Dan Du; Yugang Zhang; Canjun Zhu; Hong Chen; Jia Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-08       Impact factor: 5.555

8.  Career perspective: John W. Severinghaus.

Authors:  John W Severinghaus
Journal:  Extrem Physiol Med       Date:  2013-10-07

9.  H2S Regulates Hypobaric Hypoxia-Induced Early Glio-Vascular Dysfunction and Neuro-Pathophysiological Effects.

Authors:  Gaurav Kumar; Aastha Chhabra; Shalini Mishra; Haroon Kalam; Dhiraj Kumar; Ramniwas Meena; Yasmin Ahmad; Kalpana Bhargava; Dipti N Prasad; Manish Sharma
Journal:  EBioMedicine       Date:  2016-03-28       Impact factor: 8.143

10.  Effect of Intranasally Delivered rh-VEGF165 on Angiogenesis Following Cerebral Hypoxia-Ischemia in the Cerebral Cortex of Newborn Piglets.

Authors:  Amit Jain; Panagiotis Kratimenos; Ioannis Koutroulis; Amishi Jain; Amulya Buddhavarapu; Jahan Ara
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.